simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 16;5^{th}-Individual ID 16;5^{th}-Individual ID 16;5^{th}-Individual ID 16;5^{th}-Individual ID 16;;;95^{th}-Individual ID 12;95^{th}-Individual ID 12;95^{th}-Individual ID 12;95^{th}-Individual ID 12;95^{th}-Individual ID 12
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-1.97695890257567e-16;-0.212350766694255;-1.97695890257567e-16;-1.97695890257567e-16;-1.97695890257567e-16;;;-0.202565884223629;-0.311046360075856;-1.97695890257567e-16;-0.202565884223629;-1.97695890257567e-16
;-6.21231057243288e-15;-0.58819425853486;-6.21231057243288e-15;-6.21231057243288e-15;-6.21231057243288e-15;;;-0.596221241993006;-0.648108030287177;-6.21231057243288e-15;-0.596221241993006;-6.21231057243288e-15
;5.81691879191775e-15;0.16349272514635;5.81691879191775e-15;5.81691879191775e-15;5.81691879191775e-15;;;0.191089473545748;0.0260153101354651;5.81691879191775e-15;0.191089473545748;5.81691879191775e-15
;-Inf;0.518696623840835;-Inf;-Inf;-Inf;;;0.471996048412853;0.741933092648468;-Inf;0.471996048412853;-Inf
;0.181690113816209;0.170007314871398;0.181690113816209;0.181690113816209;0.181690113816209;;;0.200026959872682;0.0606657915089396;0.181690113816209;0.200026959872682;0.181690113816209
